Open AccessHigh cholinesterase predicts tolerance to sorafenib treatment and improved prognosis in patients with transarterial chemoembolization refractory intermediate stage hepatocellular carcinoma
Author(s) -
Shintaro Takaki,
Takayuki Fukuhara,
Nami Mori,
Keiji Tsuji
Publication year - 2019
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2019.1949
Subject(s) - sorafenib , hepatocellular carcinoma , medicine , refractory (planetary science) , univariate analysis , gastroenterology , retrospective cohort study , stage (stratigraphy) , progressive disease , oncology , multivariate analysis , disease , biology , paleontology , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom